Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow (QoQ) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Free Cash Flow (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 115.75 Mn | 87.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.32% |
| Jun 30, 2025 | -1.08% |
| Mar 31, 2025 | -50.07% |
| Dec 31, 2024 | 21.52% |
| Sep 30, 2024 | -55.88% |
| Jun 30, 2024 | -15.35% |
| Mar 31, 2024 | -28.83% |
| Dec 31, 2023 | 16.66% |
| Sep 30, 2023 | 7.42% |
| Jun 30, 2023 | 48.39% |
| Mar 31, 2023 | -102.75% |
| Dec 31, 2022 | -2.90% |
| Sep 30, 2022 | 40.76% |
| Jun 30, 2022 | -15.06% |
| Mar 31, 2022 | -8.94% |
| Dec 31, 2021 | -1,238.54% |
| Sep 30, 2021 | 104.89% |
| Jun 30, 2021 | 19.63% |
| Mar 31, 2021 | -20.02% |
| Dec 31, 2020 | 33.46% |